The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 10, 2011, Pages 2389-2394

  John, Stephen G ^a   Owen, Paul J ^a   Harrison, Laura E A ^a   Szeto, Cheuk Chun ^b   Lai, Ka Bik ^b   Li, Philip K T ^b   Mcintyre, Christopher W ^a,c  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTOXEMIA; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; PULSE WAVE; TONOMETRY; VASODILATATION;

EID: 80053912486     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11211210     Document Type: Article

References (29)

1. Charalambous BM, Stephens RC, Feavers IM, Montgomery HE: Role of bacterial endotoxin in chronic heart failure: The gut of the matter. Shock 28: 15-23, 2007
2. Lumsden AB, Henderson JM, Kutner MH: Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232-236, 1988
3. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284-288, 1998
4. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ: Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79: 1426-1430, 1997
5. Krack A, Sharma R, Figulla HR, Anker SD: The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 26: 2368-2374, 2005
6. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk HD, Lochs H, Anker SD: Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50: 1561-1569, 2007
7. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD: Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 353: 1838-1842, 1999
8. Peschel T, Schonauer M, Thiele H, Anker SD, Schuler G, Niebauer J: Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail 5: 609-614, 2003
9. Markum HM, Suhardjono, Pohan HT, Suhendro, Lydia A, Inada K: Endotoxin in patients with terminal renal failure undergoing dialysis with re-processing dialyser. Acta Med Indones 36: 93-96, 2004
10. Nisbeth U, Hallgren R, Eriksson O, Danielson BG: Endotoxemia in chronic renal failure. Nephron 45: 93-97, 1987
11. Szeto CC, Kwan BC, Chow KM, Lai KB, Chung KY, Leung CB, Li PK: Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 3: 431-436, 2008
12. Goncalves S, Pecoits-Filho R, Perreto S, Barberato SH, Stinghen AE, Lima EG, Fuerbringer R, Sauthier SM, Riella MC: Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant 21: 2788-2794, 2006
13. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK: Circulating endotoxemia: A novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 6: 133-141, 2011
14. Yu AW, Nawab ZM, Barnes WE, Lai KN, Ing TS, Daugirdas JT: Splanchnic erythrocyte content decreases during hemodialysis: A new compensatory mechanism for hypovolemia. Kidney Int 51: 1986-1990, 1997
15. Jakob SM, Ruokonen E, Vuolteenaho O, Lampainen E, Takala J: Splanchnic perfusion during hemodialysis: Evidence for marginal tissue perfusion. Crit Care Med 29: 1393-1398, 2001
16. Khanna A, Rossman JE, Fung HL, Caty MG: Intestinal and hemodynamic impairment following mesenteric ischemia/ reperfusion. J Surg Res 99: 114-119, 2001
17. Caridis DT, Reinhold RB, Woodruff PW, Fine J: Endotoxaemia in man. Lancet 1: 1381-1385, 1972
18. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN: Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 20: 1090-1096, 1992
19. Freudenberg MA, Galanos C: Metabolism of LPS in vivo. In: Bacterial endotoxic lipopolysaccharides, edited by Morrison DC, Ryan, JL, Boca Raton, FL, CRC Press, 1992, pp 275-294
20. Skarnes RC: In vivo distribution and detoxification of endotoxins. In: Handbook of endotoxins, edited by Berry LJ, Amsterdam, The Netherlands, Elsevier, 1984, pp 56-81
21. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371, 2006
22. Sigrist M, Bungay P, Taal MW, McIntyre CW: Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 21: 707-714, 2006
23. Harris HW, Grunfeld C, Feingold KR, Rapp JH: Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86: 696-702, 1990
24. Liao W, Floren CH: Hyperlipidemic response to endotoxin-a part of the host-defence mechanism. Scand J Infect Dis 25: 675-682, 1993
25. Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL: Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9: 872-878, 2007
26. Siragy HM: Improving vascular function in hypertension: Potential benefits of combination therapy with amlodipine and renin-angiotensin-aldosterone system blockers. J Hypertens 28: 2-8, 2010
27. Morishita T, Tsutsui M, Shimokawa H, Tasaki H, Suda O, Kobayashi K, Horiuchi M, Okuda H, Tsuda Y, Yanagihara N, Nakashima Y: Long-term treatment with perindopril ameliorates dobutamine-induced myocardial ischemia in patients with coronary artery disease. Jpn J Pharmacol 88: 100-107, 2002
28. Schmermund A, Lerman LO, Ritman EL, Rumberger JA: Cardiac production of angiotensin II and its pharmacologic inhibition: Effects on the coronary circulation. Mayo Clin Proc 74: 503-513, 1999
29. Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y: Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol 21: 1497-1506, 1993